Modulation of Insulin Sensitivity of Hepatocytes by the Pharmacological Downregulation of Phospholipase D

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Babenko, Nataliya A ^a   Kharchenko, Vitalina S ^a  

^a V N KARAZIN KHARKIV NATIONAL UNIVERSITY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALCOHOL; APIGETRIN; BUTANOL; CERAMIDE; DOXORUBICIN; ENZYME INHIBITOR; HALOPEMIDE; LUTEOLIN 7 GLUCOSIDE; N HEXANOYLSPHINGOSINE; PHOSPHATIDYLBUTANOL; PHOSPHATIDYLETHANOL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D; PROPRANOLOL; PROTEIN KINASE B; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; INSULIN SENSITIVITY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84935883016     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/794838     Document Type: Article

References (79)

1. D. A. Foster, D. Salloum, D. Menon, and M. A. Frias, "Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR)," The Journal of Biological Chemistry, vol. 289, no. 33, pp. 22583-22588, 2014.
2. C. Zhang, A. A. Wendel, M. R. Keogh, T. E. Harris, J. Chen, and R. A. Coleman, "Glycerolipid signals alter mTOR complex (mTORC2) to diminish insulin signaling," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 5, pp. 1667-1672, 2012.
3. R. Slaaby, G. Du, Y. M. Altshuller, M. A. Frohman, and K. Seedorf, "Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase Cgamma and protein kinase Calpha signalling cascade," Biochemical Journal, vol. 351, no. 3, pp. 613-619, 2000.
4. V. Donchenko, A. Zannetti, and P. M. Baldini, "Insulinstimulated hydrolysis of phosphatidylcholine by phospholipase C and phospholipase D in cultured rat hepatocytes," Biochimica et Biophysica Acta, vol. 1222, no. 3, pp. 492-500, 1994.
5. P. Karnam, M. L. Standaert, L. Galloway, and R. V. Farese, "Activation and translocation of Rho (and ADP ribosylation factor) by insulin in rat adipocytes: apparent involvement of phosphatidylinositol 3-kinase," The Journal of Biological Chemistry, vol. 272, no. 10, pp. 6136-6140, 1997.
6. B. T. Andresen, M. A. Rizzo, K. Shome, and G. Romero, "The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade," FEBS Letters, vol. 531, no. 1, pp. 65-68, 2002.
7. Y.-G. Chen, A. Siddhanta, C. D. Austin et al., "Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network," Journal of Cell Biology, vol. 138, no. 3, pp. 495-504, 1997.
8. M. McDermott, M. J. O. Wakelam, and A. J. Morris, "PhospholipaseD," BiochemistryandCell Biology, vol. 82, no. 1, pp. 225-253, 2004.
9. A. Honda, M. Nogami, T. Yokozeki et al., "Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation," Cell, vol. 99, no. 5, pp. 521-532, 1999.
10. G. di Paolo, H. S. Moskowitz, K. Gipson et al., "Impaired Ptdlns(4, 5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking," Nature, vol. 431, no. 7007, pp. 415-422, 2004.
11. Y. Jun, R. A. Fratti, and W. Wickner, "Diacylglycerol and its formation by phospholipase C regulate Rab-and SNAREdependent yeast vacuole fusion," The Journal of Biological Chemistry, vol. 279, no. 51, pp. 53186-53195, 2004.
12. R. V. Farese, "Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states," The American Journal of Physiology: Endocrinology and Metabolism, vol. 283, no. 1, pp. E1-E11, 2002.
13. P. Huang, Y. M. Altshuller, J. C. Hou, J. E. Pessin, and M. A. Frohman, "Insulin-stimulated plasma membrane fusion of Glut4 glucose transporter-containing vesicles is regulated by phospholipase D1," Molecular Biology of the Cell, vol. 16, no. 6, pp. 2614-2623, 2005.
14. Y. Xu, B. R. Rubin, C. M. Orme et al., "Dual-mode of insulin action controls GLUT4 vesicle exocytosis," The Journal of Cell Biology, vol. 193, no. 4, pp. 643-653, 2011.
15. R. V. Farese, M. C. Lee, and M. P. Sajan, "Hepatic atypical protein kinase C: an inherited survival-longevity gene that now fuels insulin-resistant syndromes of obesity, themetabolic syndrome and type 2 diabetes mellitus," Journal of Clinical Medicine, vol. 3, no. 3, pp. 724-740, 2014.
16. M. P. Corcoran, S. Lamon-Fava, and R. A. Fielding, "Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise," American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 662-677, 2007.
17. C. Limatola, D. Schaap, W. H. Moolenaar, and W. J. van Blitterswijk, "Phosphatidic acid activation of protein kinase C-χ overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids," Biochemical Journal, vol. 304, no. 3, pp. 1001-1008, 1994.
18. M. Matsumoto, W. Ogawa, K. Akimoto et al., "PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity," Journal of Clinical Investigation, vol. 112, no. 6, pp. 935-944, 2003.
19. S. Karim, D. H. Adams, and P. F. Lalor, "Hepatic expression and cellular distribution of the glucose transporter family," World Journal of Gastroenterology, vol. 18, no. 46, pp. 6771-6781, 2012.
20. N. A. Babenko and V. S. Kharchenko, "Ceramides inhibit phospholipase D-dependent insulin signaling in liver cells of old rats," Biochemistry, vol. 77, no. 2, pp. 180-186, 2012.
21. N. A. Babenko and V. S. Kharchenko, "Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats," Biochemistry, vol. 80, no. 1, pp. 104-112, 2015.
22. A. Y. Petrenko and A. N. Sukach, "Isolation of intact mitochondria and hepatocytes using vibration," Analytical Biochemistry, vol. 194, no. 2, pp. 326-329, 1991.
23. M. M. Billah and J. C. Anthes, "The regulation and cellular functions of phosphatidylcholine hydrolysis," Biochemical Journal, vol. 269, no. 2, pp. 281-291, 1990.
24. G. Moehren, L. Gustavsson, and J. B. Hoek, "Activation and desensitization of phospholipase D in intact rat hepatocytes," The Journal of Biological Chemistry, vol. 269, no. 2, pp. 838-848, 1994.
25. J. H. Exton, "Regulation of phospholipase D," FEBS Letters, vol. 531, no. 1, pp. 58-61, 2002.
26. Z. Kiss, J. Chattopadhyay, and G. R. Pettit, "Stimulation of phosphatidylcholine synthesis by activators of protein kinase C is dissociable from increased phospholipid hydrolysis," Biochemical Journal, vol. 273, no. 1, pp. 189-194, 1991.
27. T. Brutman-Barazani, M. Horovitz-Fried, S. Aga-Mizrachi et al., "Protein kinase Cδ but not PKCα is involved in insulininduced glucose metabolism in hepatocytes," Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 2064-2076, 2012.
28. E. G. Bligh and W. J. Dyer, "A rapid method of total lipid extraction and purification," Canadian Journal of Biochemistry and Physiology, vol. 37, no. 8, pp. 911-917, 1959.
29. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randal, "Protein measurement with the folin phenol reagent," The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
30. M. L. Standaert, A. Avignon, K. Yamada, G. Bandyopadhyay, and R. V. Farese, "The phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits insulin-induced activation of phosphatidylcholine hydrolysis and associated protein kinase C translocation in rat adipocytes," Biochemical Journal, vol. 313, no. 3, pp. 1039-1046, 1996.
31. M. A. Rizzo, K. Shome, C. Vasudevan et al., "Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of themitogen-activated protein kinase pathway," The Journal of Biological Chemistry, vol. 274, no. 2, pp. 1131-1139, 1999.
32. M. Emoto, J. K. Klarlund, S. B. Waters et al., "A role for phospholipase D in GLUT4 glucose transporter translocation," The Journal of Biological Chemistry, vol. 275, no. 10, pp. 7144-7151, 2000.
33. S. A. Q. Scott, T. P. Mathews, P. T. Ivanova, C. W. Lindsley, and H. A. Brown, "Chemical modulation of glycerolipid signaling and metabolic pathways," Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1841, no. 8, pp. 1060-1084, 2014.
34. W. Su, O. Yeku, S. Olepu et al., "5-Fluoro-2-indolyl deschlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis," Molecular Pharmacology, vol. 75, no. 3, pp. 437-446, 2009.
35. S. J. Pasquare, V. L. Gaveglio, and N. M. Giusto, "Regulation of phosphatidic acid metabolism by sphingolipids in the central nervous system," Journal of Lipids, vol. 2011, Article ID 342576, pages, 2011.
36. L. Arana, P. Gangoiti, A. Ouro, M. Trueba, and A. Gamez-Muoz, "Ceramide and ceramide 1-phosphate in health and disease," Lipids in Health and Disease, vol. 9, article 15, 2010.
37. P. E. Selvy, R. R. Lavieri, C. W. Lindsley, and H. A. Brown, "Phospholipase D: enzymology, functionality, and chemical modulation," Chemical Reviews, vol. 111, no. 10, pp. 6064-6119, 2011.
38. S. Mebarek, H. Komati, F. Naro et al., "Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentation," Journal of Cell Science, vol. 120, no. 3, pp. 407-416, 2007.
39. R. Martinez, R. Navarro, M. Lacort, J. I. Ruiz-Sanz, and M. B. Ruiz-Larrea, "Doxorubicin induces ceramide and diacylglycerol accumulation in rat hepatocytes through independent routes," Toxicology Letters, vol. 190, no. 1, pp. 86-90, 2009.
40. C. A. Dumitru, A. Carpinteiro, T. Trarbach, U. R. Hengge, and E. Gulbins, "Doxorubicin enhances TRAIL-induced cell death via ceramide-enrichedmembrane platforms," Apoptosis, vol. 12, no. 8, pp. 1533-1541, 2007.
41. G. Rath, C. Schneider, B. Langlois et al., "De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma," International Journal of Biochemistry and Cell Biology, vol. 41, no. 5, pp. 1165-1172, 2009.
42. E. A. de Lima, C. O. de Souza, A. A. de Souza Teixeira, H. Batatinha, F. de Santos Lira, and J. Neto, "Doxorubicin leads to impaired insulin signaling in skeletal muscle," Cancer and Metabolism, vol. 2, supplement 1, article P2, 2014.
43. S. Arunachalam, P. B. T. Pichiah, and Sh. Achiraman, "Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models," FEBS Letters, vol. 587, no. 2, pp. 105-110, 2013.
44. J. M. Wadsworth, D. J. Clarke, S. A. Mcmahon et al., "The chemical basis of serine palmitoyltransferase inhibition by myriocin," Journal of the American Chemical Society, vol. 135, no. 38, pp. 14276-14285, 2013.
45. C. Luberto, D. F. Hassler, P. Signorelli et al., "Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase," The Journal of Biological Chemistry, vol. 277, no. 43, pp. 41128-41139, 2002.
46. J. Kornhuber, Ph. Tripal, M. Reichel et al., "Functional inhibitors of acid sphingomyelinase (FIASMAS): a novel pharmacological group of drugs with broad clinical applications," Cellular Physiology and Biochemistry, vol. 26, no. 1, pp. 9-20, 2010.
47. M. Nomura, T. Takahashi, N. Nagata et al., "Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells," Biological and Pharmaceutical Bulletin, vol. 31, no. 7, pp. 1403-1409, 2008.
48. C. Bumke-Vogt, M. A. Osterhoff, A. Borchert et al., "The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells," PLoS ONE, vol. 9, no. 8, Article ID e104321, 2014.
49. N. A. Babenko and E. G. Shakhova, "Effects of Chamomilla recutita flavonoids on age-related liver sphingolipid turnover in rats," Experimental Gerontology, vol. 41, no. 1, pp. 32-39, 2006.
50. N. A. Babenko and E. G. Shakhova, "Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells," Lipids in Health and Disease, vol. 7, no. 1, article 1, 2008.
51. S. B. Biddinger, A. Hernandez-Ono, C. Rask-Madsen et al., "Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis," CellMetabolism, vol. 7, no. 2, pp. 125-134, 2008.
52. M. D. Michael, R. N. Kulkarni, C. Postic et al., "Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction," Molecular Cell, vol. 6, no. 1, pp. 87-97, 2000.
53. R. V. Farese Jr., R. Zechner, Ch. B. Newgard, and T. C. Walther, "The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance," Cell Metabolism, vol. 15, no. 5, pp. 570-573, 2012.
54. N. A. Babenko and V. S. Kharchenko, "The role of ceramides in insulin signalling failure in rat diaphragm in vivo and in vitro," The Problem of Endocrine Pathology, no. 1, pp. 37-43, 2009.
55. N. A. Babenko and V. S. Kharchenko, "Effects of aging and experimentally induced modifications of signal pathways on insulin-induced shifts of glucose metabolism in the rat neocortex," Neurophysiology, vol. 47, no. 1, pp. 16-22, 2015.
56. K. Shome, C. Vasudevan, and G. Romero, "ARF proteins mediate insulin-dependent activation of phospholipase D," Current Biology, vol. 7, no. 6, pp. 387-396, 1997.
57. H.-S. Li, K. Shome, R. Rojas et al., "The guanine nucleotide exchange factor ARNO mediates the activation of ARF and phospholipase D by insulin," BMC Cell Biology, vol. 4, article 13, 2003.
58. S. Sozzani, D. E. Agwu, C. E. McCall et al., "Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C,"The Journal of Biological Chemistry, vol. 267, no. 28, pp. 20481-20488, 1992.
59. Z. Kiss, "Sphingosine-like stimulatory effects of propranolol on phospholipase D activity in NIH 3T3 fibroblasts," Biochemical Pharmacology, vol. 47, no. 9, pp. 1581-1586, 1994.
60. M. Bobeszko, R. Czajkowski, M. Wojcik et al., "Modulation by cationic amphiphilic drugs of serine base-exchange, phosholipase D and intracellular calcium homeostasis in glioma C6 cells," Polish Journal of Pharmacology, vol. 54, no. 5, pp. 483-493, 2002.
61. C. Zhang, G. Hwarng, D. E. Cooper et al., "Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol," The Journal of Biological Chemistry, vol. 290, no. 6, pp. 3519-3528, 2015.
62. A. E. M. Seiler, A. Henderson, and R. Rubin, "Ethanol inhibits insulin receptor tyrosine kinase," Alcoholism: Clinical and Experimental Research, vol. 24, no. 12, pp. 1869-1872, 2000.
63. J. Xu, J. E. Yeon, H. Chang et al., "Ethanol impairs insulinstimulated neuronal survival in the developing brain role of pten phosphatase," The Journal of Biological Chemistry, vol. 278, no. 29, pp. 26929-26937, 2003.
64. C. Rauch and P. T. Loughna, "C2C12 skeletal muscle cells exposure to phosphatidylcholine triggers IGF-1 like-responses," Cellular Physiology and Biochemistry, vol. 15, no. 5, pp. 211-224, 2005.
65. H. C. Chen, G. Bandyopadhyay, M. P. Sajan, Y. Kanoh, M. Standaert, and R. V. Farese Jr., "Activation of the ERK pathway and atypical protein kinase C isoforms in exercise-and aminoimidazole-4-carboxamide-1-β-D-riboside (AICAR)-stimulated glucose transport," The Journal of Biological Chemistry, vol. 277, no. 26, pp. 23554-23562, 2002.
66. L. Waselle, R. R. L. Gerona, N. Vitale, T. F. J. Martin, M.-F. Bader, and R. Regazzi, "Role of phosphoinositide signaling in the control of insulin exocytosis,"Molecular Endocrinology, vol. 19, no. 12, pp. 3097-3106, 2005.
67. W. Su, O. Yeku, S. Olepu et al., "5-Fluoro-2-indolyl deschlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis," Molecular Pharmacology, vol. 75, no. 3, pp. 437-446, 2009.
68. F. Chen, A. Ghosh, and B. L. Shneider, "Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1," The Journal of Lipid Research, vol. 54, no. 2, pp. 379-385, 2013.
69. L.-N. Chen, J. Lyu, X.-F. Yang et al., "Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice," International Journal of Molecular Medicine, vol. 32, no. 4, pp. 892-900, 2013.
70. D. Yu, C. Y. Sun, G. P. Sun et al., "The synergistic effect of FGF-21 and insulin on regulating glucose metabolism and its mechanism," Yao Xue Xue Bao, vol. 49, no. 7, pp. 977-984, 2014.
71. R. A. Ivey, M. P. Sajan, and R. V. Farese, "Requirements for pseudosubstrate arginine residues during autoinhibition and phosphatidylinositol 3, 4, 5-(PO4)3-dependent activation of atypical PKC,"The Journal of Biological Chemistry, vol. 289, no. 36, pp. 25021-25030, 2014.
72. N. A. Bourbon, L. Sandirasegarane, and M. Kester, "Ceramideinduced inhibition of Akt is mediated through protein kinase Cβ. Implications for growth arrest," The Journal of Biological Chemistry, vol. 277, no. 5, pp. 3286-3292, 2002.
73. I. N. Singh, L. M. Stromberg, S. G. Bourgoin, V. A. Sciorra, A. J. Morris, and D. N. Brindley, "Ceramide inhibition of mammalian phospholipase D1 and D2 activities is antagonized by phosphatidylinositol 4, 5-bisphosphate," Biochemistry, vol. 40, no. 37, pp. 11227-11233, 2001.
74. A. Abousalham, C. Liossis, L. OBrien, and D. N. Brindley, "Cellpermeable ceramides prevent the activation of phospholipaseD by ADP-ribosylation factor and RhoA,"TheJournal of Biological Chemistry, vol. 272, no. 2, pp. 1069-1075, 1997.
75. A. Gidwani, H. A. Brown, D. Holowka, and B. Baird, "Disruption of lipid order by short-chain ceramides correlates with inhibition of phospholipase D and downstream signaling by FcERI," Journal of Cell Science, vol. 116, no. 15, pp. 3177-3187, 2003.
76. T. Mizutani, S. Nakashima, and Y. Nozawa, "Changes in the expression of protein kinase C (PKC), phospholipases C (PLC) and D (PLD) isoforms in spleen, brain and kidney of the aged rat: RT-PCR and Western blot analysis," Mechanisms of Ageing and Development, vol. 105, no. 1-2, pp. 151-172, 1998.
77. N. A. Babenko and V. S. Kharchenko, "Age-related changes in the phospholipase d-dependent signal pathway of insulin in the rat neocortex," Neurophysiology, vol. 45, no. 2, pp. 120-127, 2013.
78. P. A. Ruiz and D. Haller, "Functional diversity of flavonoids in the inhibition of the proinflammatory NF-βB, IRF, and Akt signaling pathways inmurine intestinal epithelial cells," Journal of Nutrition, vol. 136, no. 3, pp. 664-671, 2006.
79. Ch. M. Park and Y.-S. Song, "Luteolin and luteolin-7-Oglucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-κB/AP-1/PI3K-Akt signaling cascades in RAW 264. 7 cells," Nutrition Research and Practice, vol. 7, no. 6, pp. 423-429, 2013.